课题基金 / 基金详情

Aging and Myocardial Progenitor Recruitment

Aging and Myocardial Progenitor Recruitment
衰老与心肌祖细胞招募
批准号:
7908043
负责人:
RICHARD T LEE
金额:
$9.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2010-08-31

项目摘要

项目成果

RICHARD T LEE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):心血管系统衰老的特征是心脏功能下降,心血管疾病经常在后半生发作。许多实验结果表明,成年哺乳动物心肌中存在大量具有分化潜能的心肌干细胞,可分化为心肌细胞和其他类型的细胞,如内皮细胞和血管平滑肌细胞。像其他干细胞一样,心脏干细胞可能会随着年龄的增长而发生衰老变化,可能会降低它们的再生潜力。我们的实验室开发了一种基因细胞命运图方法来量化心肌细胞的周转,我们使用这个系统来证明在生命的前半部分,在没有损伤的情况下,心肌细胞不会被干细胞/前体细胞取代;然而,在心肌梗死后,有一个干细胞/前体池被激活。遗传命运图是一种有效的细胞追踪方法,但它不能同时量化已识别的细胞群体的细胞分裂率。直到最近,追踪细胞分裂的方法主要依赖于BrdU掺入或氚标记;这些技术有局限性,因为它们并不总是有足够的分辨率来定量追踪细胞分裂,而且在某些情况下它们可能是有毒的。一种名为多同位素成像质谱学(MIMS)的新技术有可能克服这些缺点,允许对细胞分裂历史进行定量评估。MIMS的灵敏度允许在广泛的时间范围内监测变化,因为标记脉冲是使用对动物和人类无毒的稳定、非放射性同位素产生的。由于稳定的同位素不会衰变或发射辐射,MIMS可以监测细胞在体外和体内的分裂,时间范围可能从几分钟到几年不等。在这项建议中,我们描述了使用遗传细胞命运图和MIMS的互补技术来研究老龄小鼠心肌祖细胞招募的实验,这些技术相结合将有助于定量跟踪不同的细胞群体及其细胞分裂的相对速率。我们的具体目标是:目的1.验证在没有损伤的情况下,衰老小鼠心肌细胞不会被前体细胞显著刷新的假设。目的2.验证衰老通过干细胞/前体细胞库降低哺乳动物心肌细胞更新能力的假说。目的:验证以下假设:稳定同位素MIMS定量结合遗传命运定位揭示了成年哺乳动物心肌细胞在衰老过程中基础细胞分裂率较低,而前体细胞池中的细胞分裂没有可测量的贡献。目的4:验证损伤后心肌细胞主要由干细胞补充的假说,而不是通过预先存在的心肌细胞的细胞分裂来补充,而不是年龄。公共卫生相关性:心脏病经常发生在生命的后半段,心脏组织的愈合和再生可能会因衰老过程而受损。该项目使用新的复杂方法来确定心脏的愈合过程是否会随着老鼠的年龄而变化。这些实验将为了解美国的老龄化过程和最常见的死亡原因提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): Aging of the cardiovascular system is characterized by a reduction in cardiac function, and cardiovascular disease frequently strikes in the latter half of life. Many experimental findings suggest that adult mammalian myocardium has a population of resident cardiac stem cells with differentiation potential for cardiomyocytes and other cell types like endothelial cells and vascular smooth muscle cells. Like other stem cells, cardiac stem cells may be subject to senescent changes with increasing age, possibly reducing their regenerative potential. Our laboratory has developed a genetic cell fate-mapping approach to quantify cardiomyocyte turnover, and we have used this system to demonstrate that in the first half of life, cardiomyocytes are not replaced by stem/precursor cells in the absence of injury; however, after myocardial infarction, there is activation of a stem/precursor pool. Genetic fate-mapping is a powerful approach for cell tracking, but it cannot simultaneously quantify cell division rates of the identified cell populations. Until recently, methods for tracking cell division relied mainly on BrdU incorporation or tritium (3H) labeling; these techniques have limitations because they do not always have sufficient resolution to track cell divisions quantitatively, and they can be toxic under certain circumstances. A new technology called Multi-Isotope Imaging Mass Spectrometry (MIMS) has the potential to overcome these drawbacks, permitting quantitative assessment of cell division history. The sensitivity of MIMS allows changes to be monitored over a wide range of times because a labeling pulse is generated using stable, nonradioactive isotopes that are non-toxic for animals and humans. MIMS can monitor cell division in vitro and in vivo with time scales potentially ranging from minutes to years, since stable isotopes do not decay or emit radiation. In this proposal, we describe experiments to study myocardial progenitor recruitment in aging mice using the complementary techniques of genetic cell fate-mapping and MIMS, which in combination will facilitate quantitative tracking of different cell populations and their relative rates of cell division. Our specific aims are: Aim 1. To test the hypothesis that in the absence of injury, cardiomyocytes are not significantly refreshed by precursor cells in the aging mouse. Aim 2. To test the hypothesis that aging reduces the capacity of mammalian myocardium to refresh cardiomyocytes by the stem/precursor cell pool following injuries representative of human diseases. Aim 3: To test the hypothesis that stable isotope MIMS quantification combined with genetic fate mapping reveals a low rate of basal cardiomyocyte cell division with no measurable contribution of cell division from a precursor pool in adult mammalian myocardium during aging. Aim 4: To test the hypothesis that, following injury, cardiomyocytes are replenished primarily by stem cells and not by cell division of pre-existing cardiomyocytes irrespective of age. PUBLIC HEALTH RELEVANCE: Heart disease frequently strikes in the latter half of life, and healing and regeneration of heart tissue may be impaired by the aging process. This project uses new sophisticated methods to determine if the healing process of the heart changes as mice age. These experiments will provide new insight into the aging process and the most common causes of death in the United States.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myocardial Physiology of Growth Differentiation Factor Signaling
  • 批准号:
    10711086
  • 项目类别:
  • 资助金额:
    $60.85万
  • 财政年份:
    2023
  • 负责人:
    RICHARD T LEE
  • 依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
  • 批准号:
    10320336
  • 项目类别:
  • 资助金额:
    $42.25万
  • 财政年份:
    2021
  • 负责人:
    RICHARD T LEE
  • 依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
  • 批准号:
    10095220
  • 项目类别:
  • 资助金额:
    $42.25万
  • 财政年份:
    2021
  • 负责人:
    RICHARD T LEE
  • 依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
  • 批准号:
    10540314
  • 项目类别:
  • 资助金额:
    $42.25万
  • 财政年份:
    2021
  • 负责人:
    RICHARD T LEE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: